Antibody Therapeutics for Life


PharmAbcine, 20th EDQM MAB Working Party
  • Written by PharmAbcine
  • Written date 2019-10-17 09:09:36
  • Inquire 5400

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and CEO of PharmAbcine and Expert of EDQM MAB Working Party ( is participating the 20th EDQM MAB Working Party meeting on October 16-17, 2019.


Prev 2019 China BioMed Innovation and Investment Conference
Next PharmAbcine, AUSBIOTECH 2019